Patent classifications
A61K36/39
COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES INCLUDING ANTI-TUMOR EFFECTS
In one aspect, a composition of ginsenoside Rg3 and ginsenoside Rg5 and a preparation method thereof, as well as its application in manufacturing drugs, foods and health products for boosting immunity, enhancing anti-tumor effects, improving resistance to anti-tumor targeted drugs, mitigating toxic and side effects of radiotherapy and chemotherapy or improving anti-fatigue effects. The composition has advantages in rapid action, less toxicity and side effects and is suitable for long-term use. In another aspect, a safe, highly efficient and stable drug, food or health product which can be obtained by a simple preparation process suitable for industrial production and which can be easily scaled up. In yet another aspect, a new type of components and production process for manufacturing drugs, foods and health products for boosting immunity, enhancing anti-tumor effect, improving resistance to anti-tumor targeted drugs, mitigating toxic and side effects of radiotherapy and chemotherapy or improving anti-fatigue effect.
Methods and materials for treating diabetes or liver steatosis
This document provides methods and materials for treating diabetes and/or liver steatosis. For example, methods for using compositions containing a potato polysaccharide preparation to reduce one or more symptoms of diabetes or liver steatosis are provided. In some cases, a composition containing a potato polysaccharide preparation provided herein can be used to treat fatty liver disease.
Methods and materials for treating diabetes or liver steatosis
This document provides methods and materials for treating diabetes and/or liver steatosis. For example, methods for using compositions containing a potato polysaccharide preparation to reduce one or more symptoms of diabetes or liver steatosis are provided. In some cases, a composition containing a potato polysaccharide preparation provided herein can be used to treat fatty liver disease.
Methods and materials for treating diabetes or liver steatosis
This document provides methods and materials for treating diabetes and/or liver steatosis. For example, methods for using compositions containing a potato polysaccharide preparation to reduce one or more symptoms of diabetes or liver steatosis are provided. In some cases, a composition containing a potato polysaccharide preparation provided herein can be used to treat fatty liver disease.
FOOD EXTRACTS, METHODS OF EXTRACTION AND COMPOSITIONS THEREOF
The present invention relates, in general terms, to a method of extracting resin glycoside from a plant selected from the Convolvulaceae family. The resin glycosides can be extracted from Ipomoea batatas and/or Ipomoea aquatica. The present invention also relates to the extracts and edible compositions thereof and its use in weight loss and weight management.
FOOD EXTRACTS, METHODS OF EXTRACTION AND COMPOSITIONS THEREOF
The present invention relates, in general terms, to a method of extracting resin glycoside from a plant selected from the Convolvulaceae family. The resin glycosides can be extracted from Ipomoea batatas and/or Ipomoea aquatica. The present invention also relates to the extracts and edible compositions thereof and its use in weight loss and weight management.
FOOD AND SUPPLEMENT FORMULATIONS
The present disclosure relates to a companion animal (e.g. pet) food and/or supplement formulations, and more particularly to a novel animal product or by-product -free, naturally based food and/or supplement formulation that has the nutritional profile of those made with animal products (e.g. meat based).
FOOD AND SUPPLEMENT FORMULATIONS
The present disclosure relates to a companion animal (e.g. pet) food and/or supplement formulations, and more particularly to a novel animal product or by-product -free, naturally based food and/or supplement formulation that has the nutritional profile of those made with animal products (e.g. meat based).
ORAL CARE COMPOSITION COMPRISING SWEET POTATO-DERIVED POTATO SYRUP OR SUPERNATANT OF POTATO SYRUP
An oral care composition is provided. The oral care composition is configured by containing a sweet potato-derived potato syrup or a supernatant of a potato syrup.
ORAL CARE COMPOSITION COMPRISING SWEET POTATO-DERIVED POTATO SYRUP OR SUPERNATANT OF POTATO SYRUP
An oral care composition is provided. The oral care composition is configured by containing a sweet potato-derived potato syrup or a supernatant of a potato syrup.